Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials-Reference-Cited by-同舟云学术

Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials

Published:2019-08 Issue:8 Volume:14 Page:1440-1446
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sorich Michael J.^ORCID,Rowland Andrew,Karapetis Christos S.,Hopkins Ashley M.

Funder

Cancer Council SA

Pfizer

National Breast Cancer Foundation

Cancer Council SA’s

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

2. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance;Park;Exp Mol Med,2018

3. Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers;Hopkins;Br J Cancer,2017

4. Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer;Prelaj;Eur J Cancer,2019

5. Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH);Peters;J Clin Oncol,2017

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis;Pathology and Oncology Research;2024-06-20

2. Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study;Frontiers in Immunology;2024-06-07

3. Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma;European Journal of Cancer;2024-06

4. Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review;BMC Cancer;2024-04-25

5. Prognostic models for immunotherapy in non-small cell lung cancer: A comprehensive review;Heliyon;2024-04